Wall Street was trading more cautiously Tuesday following Monday’s powerful rebound. The notable action beneath the indexes included strength in select defense companies and significant company-specific weakness in healthcare.
That makes today’s contrast pretty clean: defense is playing defense, while Hims & Hers is feeling considerably less healthy.
💎 Diamond of the Day: Lockheed Martin (LMT)
Lockheed Martin earns today’s Diamond as shares traded around $604.91 at midday, up approximately 2.8%. [stockanalysis.com]
The company also announced Tuesday that it had reached a production milestone involving Guided Multiple Launch Rocket System equipment, while recent defense-company results have kept attention on demand for both conventional weapons systems and newer defense technologies. [stockanalysis.com]
Why It Shined
- Lockheed Martin was approximately 2.8% higher around midday. [stockanalysis.com]
- Shares were trading near $605. [stockanalysis.com]
- The company announced a new production milestone involving its GMLRS program Tuesday. [stockanalysis.com]
- Defense-industry demand remains an important theme across both conventional and newer military technologies. [stockanalysis.com]
🐕 Dog of the Day: Hims & Hers Health (HIMS)
Hims & Hers Health definitely qualifies for Tuesday’s doghouse.
Shares were down approximately 19% to 20% around midday, trading near $18.50, on unusually heavy volume following the company’s third-quarter report. [stockanalysis.com], [finance.yahoo.com]
Interestingly, the top-line growth remained substantial. Third-quarter revenue increased approximately 49% year over year. But investors focused on weaker profitability, subscriber trends and management’s reduced outlook. [finance.yahoo.com], [morningstar.com]
Why It Barked
- Hims & Hers Health was down approximately 19% to 20% around midday. [stockanalysis.com], [finance.yahoo.com]
- Third-quarter revenue nevertheless increased roughly 49% year over year. [finance.yahoo.com], [morningstar.com]
- Subscriber levels declined sequentially amid changes in marketing and international operations. [finance.yahoo.com]
- Morningstar reported that the company reduced the midpoint of its full-year revenue guidance by roughly 2% and adjusted EBITDA guidance by approximately 11%. [morningstar.com]
- Trading volume was already roughly 40 million shares around midday, compared with average volume near 11.4 million shares. [stockanalysis.com], [finance.yahoo.com]
Lockheed Martin provides some defense, while Hims & Hers could use a little medicine of its own.
Important Disclosure
This commentary is provided solely for informational and educational purposes and should not be considered a recommendation or solicitation to buy, sell or hold any security, sector or investment strategy. The “Diamond” and “Dog” designations reflect notable intraday market performance and/or publicly reported developments and are not intended as investment recommendations or assessments of future performance. Corporate guidance and management estimates are forward-looking and may change. Intraday prices and market conditions may change materially before the close. Past performance does not guarantee future results. Investing involves risk, including possible loss of principal.